Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
Not Applicable
Recruiting
- Conditions
- Type 1 Diabetes Mellitus With HypoglycemiaType 1 Diabetes
- Interventions
- Device: ExOlin®Drug: Insulin aspart
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Defymed
- Target Recruit Count
- 8
- Registration Number
- NCT05221359
- Locations
- 🇫🇷
Hôpitaux Universitaires de Strasbourg, Strasbourg, France
© Copyright 2025. All Rights Reserved by MedPath